Breast Cancer Clinical Trials

Showing 3901-3920 of 5,597 trials

Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer

NCT03507088

Effects of fulvestrant on the ERs may be evaluable by molecular imaging using positron emission tomography with the ER-specific FES tracer. In this study we will determine the utility of FES-PET in the prediction of response to fulvestrant 500 mg in women with estrogen positive metastatic breast cancer

Metastatic Breast Cancer

Zhimin Shao36 participantsStarted Sep 2015

Shanghai, Shanghai Municipality, China • Shanghai, China

COMPLETEDPhase 1

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

NCT01597193

The purpose of this study is to determine the safety, tolerability and pharmacokinetics of enzalutamide alone and in combination with anastrozole, or exemestane, or fulvestrant in patients with incurable breast cancer.

Breast Cancer

Pfizer101 participantsStarted Apr 2012

Aurora, Colorado, United States • Aurora, Colorado, United States • Aurora, Colorado, United States +14 more locations

Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Related Searches

Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer

Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer

A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts

Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast Cancer

Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease

Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer Under Adjuvant Radiotherapy

A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable Cancers

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

A Study to Evaluate the Use of Supine MRI Images in Breast Conserving Surgery

Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction

Phase I Study of the Combination of MLN9708 and Fulvestrant

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Intraoperative Radiation Therapy in Early Stage Breast Cancer

DTi Diffusion Findings in Breast MRI Screening and Diagnostic

Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer

Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer

Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound.

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer